Cholesterol-Lowering Medications
62 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What are the primary symptoms of ASCVD as mentioned in the text?

  • Abdominal pain and sweating
  • Loss of consciousness and difficulty with speech or movement
  • Anxiety and shortness of breath
  • Chest pain and palpitations (correct)

    • What is the recommended screening method for lipid panel in individuals before puberty?

  • High-sensitivity C-reactive protein test
  • Lipoprotein electrophoresis
  • Non-fasting lipid panel
  • Fasting lipid panel (correct)

    • What is the general approach for dyslipidemia management?

  • Healthy lifestyle and management of modifiable risk factors (correct)
  • Immediate medication intervention
  • Exclusive reliance on lipid-lowering therapies
  • Invasive surgical procedures

    • What is the primary goal of dyslipidemia therapy outcomes?

    <p>Prevent ASCVD-related morbidity and mortality</p> Signup and view all the answers

    What are the adverse drug reactions associated with Niacin?

    <p>Flushing and hyperuricemia</p> Signup and view all the answers

    How does Niacin affect HDL and LDL levels?

    <p>Decreases LDL and increases HDL</p> Signup and view all the answers

    What is a precaution for using Niacin?

    <p>Use in combination with other drugs that elevate liver function tests (LFTs)</p> Signup and view all the answers

    How can flushing associated with Niacin be decreased?

    <p>Take with food, pre-medicate with aspirin, and avoid hot liquids, spicy foods, or alcohol</p> Signup and view all the answers

    What is the main focus of ASCVD risk reduction?

    <p>Lowering LDL-C</p> Signup and view all the answers

    Which agents are considered most cost-effective for lowering LDL-C?

    <p>Statins</p> Signup and view all the answers

    What are the recommended monitoring parameters for Niacin use?

    <p>Lipid panel, LFTs, and CPK</p> Signup and view all the answers

    When should Ezetimibe, PCSK9 mAbs, ACL, inclisiran, and BAS be added in the treatment guidelines?

    <p>After maximum tolerated statin therapy</p> Signup and view all the answers

    What is the primary mechanism of action of statins?

    <p>Inhibition of HMG-CoA Reductase in cholesterol synthesis pathway</p> Signup and view all the answers

    What is a common adverse effect of statins?

    <p>Myopathy</p> Signup and view all the answers

    How are statin dosages characterized?

    <p>By expected percentage reduction in LDL-C</p> Signup and view all the answers

    What is a contraindication for the use of statins?

    <p>All of the above</p> Signup and view all the answers

    What is a monitoring parameter for statin therapy?

    <p>Lipid panel</p> Signup and view all the answers

    What is the primary mechanism of action of Ezetimibe?

    <p>Cholesterol absorption inhibition</p> Signup and view all the answers

    What is a common adverse effect of Ezetimibe?

    <p>LFT elevation</p> Signup and view all the answers

    What is a contraindication for the use of Ezetimibe?

    <p>Pregnancy/breastfeeding</p> Signup and view all the answers

    What is the recommended timing for statin administration in relation to food?

    <p>Can be administered with or without food</p> Signup and view all the answers

    What are the warnings associated with statins?

    <p>Muscle symptoms, hepatotoxicity, and drug interactions</p> Signup and view all the answers

    What is the recommended approach for routine monitoring of statin therapy?

    <p>Baseline LFTs and periodic lipid panel</p> Signup and view all the answers

    What is the range of LDL-C reduction associated with statin efficacy?

    <p>18-62%</p> Signup and view all the answers

    What type of diet is recommended for lipid-lowering therapy?

    <p>Diet emphasizing intake of vegetables, fruits, whole grains, and healthy protein sources</p> Signup and view all the answers

    How often is physical activity recommended for dyslipidemia management?

    <p>3-4 sessions per week</p> Signup and view all the answers

    What specific dietary modifications are emphasized to lower LDL-C?

    <p>Increase soluble fiber intake</p> Signup and view all the answers

    Who requires primary or secondary prevention treatment for ASCVD risk?

    <p>Patients with very high LDL-C levels, diabetes, and elevated 10-year ASCVD risk</p> Signup and view all the answers

    What is used to calculate 10-year or lifetime ASCVD risk in primary prevention?

    <p>The Pooled Cohort Equation</p> Signup and view all the answers

    What is considered in primary prevention for older adults over 75 years?

    <p>Limitations to potential benefit of statin therapy</p> Signup and view all the answers

    Who are classified as very high-risk ASCVD in the secondary prevention treatment algorithm?

    <p>Those based on major ASCVD events, high-risk conditions, and special populations</p> Signup and view all the answers

    What is recommended for patients with statin-associated muscle symptoms (SAMS)?

    <p>Re-challenge strategies</p> Signup and view all the answers

    What is aimed for in terms of LDL-C reduction for patients with a greater ASCVD risk?

    <p>Greater LDL-C reduction</p> Signup and view all the answers

    What are the initial approaches for patient management, considering cost-efficacy?

    <p>Lifestyle modifications and statin therapy</p> Signup and view all the answers

    What does the guideline emphasize in terms of treatment approaches for primary and secondary ASCVD prevention?

    <p>The importance of tailored treatment approaches</p> Signup and view all the answers

    Which medication reduces LDL by 15-20% and increases HDL by 6%?

    <p>Bempedoic Acid</p> Signup and view all the answers

    Which medication can cause GI upset, constipation, and precautions for hyperchloremic acidosis and bleeding?

    <p>Bile Acid Sequestrants</p> Signup and view all the answers

    Which medication can increase LDL by 30% and HDL by 11-13% while reducing TGs by 40-45%?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which medication reduces hepatic VLDL production, leading to a decrease in TG and LDL, with no known effect on CV morbidity and mortality?

    <p>Niacin</p> Signup and view all the answers

    Which medication is recommended as an add-on to maximally tolerated statin for specific patient groups?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which medication has potential side effects including hyperuricemia and cholelithiasis?

    <p>Bempedoic Acid</p> Signup and view all the answers

    Which medication can cause LFT elevation and abdominal pain?

    <p>Fibric Acid Derivatives</p> Signup and view all the answers

    Which medication can lead to dyspepsia and fishy burps as possible side effects?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which cholesterol-lowering medication is recommended for adults with persistent hypertriglyceridemia and specific conditions?

    <p>Bile Acid Sequestrants</p> Signup and view all the answers

    Which medication has pleiotropic effects, reducing inflammation and oxidative stress?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which cholesterol-lowering medication should patients be educated on managing fishy burps and potential drug interactions, especially with medications that increase bleeding risk?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which cholesterol-lowering medication should patients be counseled on managing drug interactions and suggesting stool softeners?

    <p>Bile Acid Sequestrants</p> Signup and view all the answers

    What is the primary focus of dyslipidemia therapy outcomes?

    <p>Prevent ASCVD-related morbidity &amp; mortality</p> Signup and view all the answers

    What is the screening method recommended for lipid panel in individuals before puberty?

    <p>Fasting lipid panel</p> Signup and view all the answers

    What is the general approach for dyslipidemia management?

    <p>Healthy lifestyle and management of modifiable risk factors</p> Signup and view all the answers

    Which medication can increase HDL by 13-35% and decrease TGs by 20-50%?

    <p>Niacin</p> Signup and view all the answers

    What is recommended for patients with statin-associated muscle symptoms (SAMS)?

    <p>Discontinuing statin therapy</p> Signup and view all the answers

    What is the most cost-effective agent for lowering LDL-C according to the text?

    <p>Statins</p> Signup and view all the answers

    What is a common adverse effect of statins?

    <p>Myopathy</p> Signup and view all the answers

    Which medication is contraindicated in pregnancy/lactation, acute liver disease, and hypersensitivity?

    <p>Ezetimibe</p> Signup and view all the answers

    How are statin dosages characterized?

    <p>By expected % reduction in LDL-C</p> Signup and view all the answers

    Which medication can increase LDL by 30% and HDL by 11-13% while reducing TGs by 40-45%?

    <p>Omega-3 Fatty Acids</p> Signup and view all the answers

    Which cholesterol-lowering medication should patients be counseled on managing drug interactions and suggesting stool softeners?

    <p>Bile Acid Sequestrants</p> Signup and view all the answers

    Which medication reduces hepatic VLDL production, leading to a decrease in TG and LDL, with no known effect on CV morbidity and mortality?

    <p>Niacin</p> Signup and view all the answers

    What is the recommended frequency of physical activity for dyslipidemia management?

    <p>3-4 sessions per week, lasting 40 minutes each</p> Signup and view all the answers

    What is the primary consideration for primary prevention in older adults over 75 years?

    <p>Potential benefits of statin therapy</p> Signup and view all the answers

    What is used to calculate 10-year or lifetime ASCVD risk in primary prevention?

    <p>Pooled Cohort Equation</p> Signup and view all the answers

    Study Notes

    Cholesterol-Lowering Medications: Mechanisms, Efficacy, and Monitoring

    • Bempedoic Acid, an ACL Inhibitor, reduces LDL by 15-20% and increases HDL by 6%, with potential side effects including hyperuricemia and cholelithiasis.
    • Bile Acid Sequestrants, such as Colestipol, decrease LDL by 15-30% and increase HDL by 6%, but can cause GI upset and constipation, with precautions for hyperchloremic acidosis and bleeding.
    • The guidelines recommend Bile Acid Sequestrants for adults with persistent hypertriglyceridemia and specific conditions, and advise on patient counseling and administration, including managing drug interactions and suggesting stool softeners.
    • Fibric Acid Derivatives, like Fenofibrate, lower LDL by 5-20% and raise HDL by 10-20%, with potential adverse effects including LFT elevation and abdominal pain.
    • Patients should be counseled on the administration and interactions of Fibric Acid Derivatives, and monitoring parameters, including lipid panels, LFTs, CPK, and renal status.
    • Omega-3 Fatty Acids, including Icosapent Ethyl, can increase LDL by 30% and HDL by 11-13%, while reducing TGs by 40-45%, with possible side effects such as dyspepsia and fishy burps.
    • Icosapent Ethyl has pleiotropic effects, reducing inflammation and oxidative stress, and is recommended as an add-on to maximally tolerated statin for specific patient groups.
    • Patients should be educated on the administration of Omega-3 Fatty Acids, and advised on managing fishy burps and potential drug interactions, especially with medications that increase bleeding risk.
    • Niacin reduces hepatic VLDL production, leading to a decrease in TG and LDL, with no known effect on CV morbidity and mortality.
    • The guidelines recommend considering Niacin for specific patient groups, and advise on patient education, administration, and potential drug interactions, especially those that increase bleeding risk.
    • The guidelines emphasize monitoring lipid panels and LFTs for various cholesterol-lowering medications, with specific timeframes for baseline and follow-up assessments.
    • The guidelines provide comprehensive information on the mechanisms, efficacy, monitoring, and patient considerations for cholesterol-lowering medications to guide clinical practice and optimize patient outcomes.

    Management of Blood Cholesterol: Key Points

    • Healthy lifestyle and diet emphasizing intake of vegetables, fruits, whole grains, and healthy protein sources is recommended for lipid-lowering therapy.
    • Physical activity of 3-4 sessions per week, lasting 40 minutes each, is recommended for dyslipidemia management.
    • Guidelines emphasize specific dietary modifications to lower LDL-C, increase soluble fiber intake, and increase HDL-C through physical activity and smoking cessation.
    • Patients with ASCVD risk, including those with very high LDL-C levels, diabetes, and elevated 10-year ASCVD risk, require primary or secondary prevention treatment.
    • Patient management groups include primary prevention for severe hypercholesterolemia, diabetes, and other high-risk patients based on risk assessment.
    • The Pooled Cohort Equation is used to calculate 10-year or lifetime ASCVD risk in primary prevention, with risk enhancers including diabetes risk factors and lipid/biomarkers.
    • Primary prevention in older adults over 75 years includes consideration of limitations to potential benefit of statin therapy.
    • Secondary prevention treatment algorithm classifies very high-risk ASCVD based on major ASCVD events, high-risk conditions, and special populations.
    • Special populations include those with statin-associated muscle symptoms (SAMS), for which re-challenge strategies are recommended, and pharmacologic treatment agents that primarily lower atherogenic cholesterol.
    • The greater the patient’s ASCVD risk, the greater LDL-C reduction is aimed for, with patients with a history of ASCVD needing secondary prevention.
    • Healthy lifestyle and statin therapy are the initial approaches for patient management, considering cost-efficacy.
    • The guidelines provide specific recommendations for primary and secondary ASCVD prevention, emphasizing the importance of risk assessment and tailored treatment approaches.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    19 20 Dyslipidemia Therapeutics.docx

    Description

    Explore the mechanisms, efficacy, and monitoring of cholesterol-lowering medications with this quiz. Test your knowledge on Bempedoic Acid, Bile Acid Sequestrants, Fibric Acid Derivatives, Omega-3 Fatty Acids, and Niacin, and learn about patient counseling, administration, potential side effects, and monitoring parameters recommended by guidelines.

    More Like This

    Lowering Cholesterol and Triglycerides Quiz
    6 questions

    Lowering Cholesterol and Triglycerides Quiz

    EducatedGlacier avatar
    EducatedGlacier
    Lowering LDL Cholesterol
    9 questions

    Lowering LDL Cholesterol

    SelfSatisfactionHeliotrope avatar
    SelfSatisfactionHeliotrope
    Pharmacology Study: Medications Overview
    5 questions

    Pharmacology Study: Medications Overview

    PunctualAstatine avatar
    PunctualAstatine
    Drugs for Atherosclerosis Prevention
    25 questions

    Drugs for Atherosclerosis Prevention

    SmoothestLlama avatar
    SmoothestLlama
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser